BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+10.55%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$850M
AUM Growth
+$850M
(-12%)
Cap. Flow
-$85.6M
Cap. Flow
% of AUM
-10.07%
Top 10 Holdings %
Top 10 Hldgs %
87.63%
Holding
26
New
2
Increased
1
Reduced
5
Closed
–
Top Buys
| 1 |
Olema Pharmaceuticals
OLMA
|
$43.6M |
| 2 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
$37.7M |
| 3 |
NewAmsterdam Pharma
NAMS
|
$6.3M |
Top Sells
| 1 |
Nuvalent
NUVL
|
$97.9M |
| 2 |
Disc Medicine
IRON
|
$51.5M |
| 3 |
Annexon
ANNX
|
$16.4M |
| 4 |
Dianthus Therapeutics
DNTH
|
$7.06M |
| 5 |
Nautilus Biotechnolgy
NAUT
|
$405K |
Sector Composition
| 1 | Healthcare | 99.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NewAmsterdam Pharma
NAMS
$2.71B
| $275M | 32.41% | 10,719,110 +245,197 | +2% | +$6.3M |
|
|
2
Nuvalent
NUVL
$5.52B
| $113M | 13.33% | 1,447,267 -1,250,000 | -46% | -$97.9M |
|
3
Pharvaris
PHVS
$1.39B
| $63.3M | 7.45% | 3,303,381 | – | – |
|
|
4
Disc Medicine
IRON
$2.07B
| $62.4M | 7.33% | 983,500 -812,235 | -45% | -$51.5M |
|
|
5
Dianthus Therapeutics
DNTH
$759M
| $58.6M | 6.9% | 2,689,707 -323,716 | -11% | -$7.06M |
|
6
Savara
SVRA
$567M
| $44.7M | 5.26% | 14,565,457 | – | – |
|
|
7
Olema Pharmaceuticals
OLMA
$375M
| $43.6M | 5.12% | +7,470,214 | New | +$43.6M |
|
|
UPB
8
Upstream Bio, Inc. Common Stock
UPB
$923M
| $37.7M | 4.44% | +2,295,322 | New | +$37.7M |
|
|
9
Annexon
ANNX
$226M
| $26.9M | 3.17% | 5,249,069 -3,200,679 | -38% | -$16.4M |
|
10
Cidara Therapeutics
CDTX
$1.66B
| $18.9M | 2.22% | 703,080 | – | – |
|
11
Solid Biosciences
SLDB
$427M
| $16.1M | 1.9% | 4,034,582 | – | – |
|
12
Kyverna Therapeutics
KYTX
$160M
| $12.6M | 1.48% | 3,368,370 | – | – |
|
13
X4 Pharmaceuticals
XFOR
$84.3M
| $12.4M | 1.46% | 16,915,784 | – | – |
|
14
Mersana Therapeutics
MRSN
$36.5M
| $12.4M | 1.46% | 8,663,673 | – | – |
|
15
Tango Therapeutics
TNGX
$747M
| $8.38M | 0.99% | 2,712,008 | – | – |
|
16
Atea Pharmaceuticals
AVIR
$267M
| $8.33M | 0.98% | 2,485,638 | – | – |
|
17
Rapid Micro Biosystems
RPID
$107M
| $7.59M | 0.89% | 8,434,560 | – | – |
|
18
Cabaletta Bio
CABA
$133M
| $6.27M | 0.74% | 2,760,888 | – | – |
|
19
Century Therapeutics
IPSC
$42.5M
| $5.46M | 0.64% | 5,410,361 | – | – |
|
20
Xilio Therapeutics
XLO
$36.3M
| $4.36M | 0.51% | 4,566,817 | – | – |
|
21
C4 Therapeutics
CCCC
$185M
| $4M | 0.47% | 1,111,910 | – | – |
|
|
22
Nautilus Biotechnolgy
NAUT
$85.9M
| $2.96M | 0.35% | 1,759,000 -241,000 | -12% | -$405K |
|
|
MRNS
23
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.44M | 0.17% | 2,693,380 | – | – |
|
|
24
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.3M
| $1.43M | 0.17% | 100,000 | – | – |
|
25
Invivyd
IVVD
$204M
| $797K | 0.09% | 1,799,595 | – | – |
|